This study investigated the effects of Galileo Therapy in Spinal Muscle Atrophy (SMA, type II, III, IIIa, age 2-7) (Cologne Concept: 3x3 minutes, 10 session/week, 26 weeks). Galileo Therapy showed significant improvements in muscle function in Gross Motor Function Test (GMFM-66, +4%) and Hammersmith Functional Mobility Scale (HFMS, +9,5%). The following 6 months of standard therapy did not show further significant improvements...
Galileo Research Facts No. 157: Can Galileo Therapy improve muscle function and gait speed in children with Ataxia?
This study shows the effect of Galileo Therapy (Cologne Concept: 3x3 minutes, 10 session/week, 26 weeks) in Ataxia patients (3-14 years, 2 groups: progressive and non-progressive). Both Galileo groups show significant improvements in GRMF66 (+7%), gait speed (+12%), 1MWT (+41%). In the following 6 months with standard therapy there was no additional relevant improvement in the parameters...
Galileo Research Facts No. 134: Can Galileo Therapy in Ataxia patients improve blood-flow and muscle activation?
This study investigated the immediate effects of Galileo Therapy with different frequencies and durations on muscle activation (EMG) and blood-flow (Galileo Delta, 45° tilt, 60° knee flexion, pos. 2.5, 10, 20, 30Hz, 1*3 vs. 3*1 min., 6 session/2 weeks). High frequencies (30Hz) during Galileo Delta Therapy showed higher effects on blood-flow (+33%), exertion (96%) and EMG Frequency (55%) compared to lower frequencies (10Hz)...